Literature DB >> 17545501

A comparison of EQ-5D index scores derived from the US and UK population-based scoring functions.

Jeffrey A Johnson, James W Shaw, Stephen Joel Coons.   

Abstract

The authors recently introduced a new preference-based scoring function for the EQ-5D (D1 model) based on time tradeoff valuations from the general adult US population: In this study, they compared the EQ-5D index scores derived from the US (D1) algorithm to the more familiar UK (N3) algorithm. They compared preference-based EQ-5D index scores for all possible EQ-5D health states and differences in EQ-5D index scores between pairs of EQ-5D health states predicted by the D1 and N3 models. The responsiveness of D1- and N3-predicted EQ-5D index scores was assessed using simulated transitions between EQ-5D health states. The mean (SD) EQ-5D index scores for all 243 health states predicted by the D1 and N3 models were 0.37 (0.23) and 0.14 (0.31), respectively. The mean (SD) absolute difference in EQ-5D index scores for all 29,403 pairs of health states was 0.25 (0.19) and 0.35 (0.27), according to the D1 and N3 models, respectively. The D1 and N3 models were consistent in predicting gains/losses for 27,592 (94%) transitions between EQ-5D health state pairs; Cohen effect size, calculated using these 27,592 consistent transitions, was 1.58 and 1.59 for the D1 and N3 models, respectively. Based on these simulation results, it appears that the D1 model would lead to smaller gains in quality-adjusted life years than the N3 model; however, their responsiveness appears to be similar. Empirical studies are needed to examine whether these 2 EQ-5D scoring functions would lead to different conclusions in cost-utility analyses.

Entities:  

Mesh:

Year:  2007        PMID: 17545501     DOI: 10.1177/0272989X07300603

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  26 in total

1.  Population-level response shift: novel implications for research.

Authors:  Darren Lau; Calypse Agborsangaya; Fatima Al Sayah; Xiuyun Wu; Arto Ohinmaa; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2011-11-18       Impact factor: 4.147

2.  The impact of using different tariffs to value EQ-5D health state descriptions: an example from a study of acute cough/lower respiratory tract infections in seven countries.

Authors:  Raymond Oppong; Billingsley Kaambwa; Jacqueline Nuttall; Kerenza Hood; Richard D Smith; Joanna Coast
Journal:  Eur J Health Econ       Date:  2011-11-05

3.  Mapping the QLQ-C30 quality of life cancer questionnaire to EQ-5D patient preferences.

Authors:  Ralph Crott; Andrew Briggs
Journal:  Eur J Health Econ       Date:  2010-05-16

4.  Utilities of the EQ-5D: transferable or not?

Authors:  Saskia Knies; Silvia M A A Evers; Math J J M Candel; Johan L Severens; André J H A Ament
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

5.  The association of survey language (Spanish vs. English) with Health Utilities Index and EQ-5D index scores in a United States population sample.

Authors:  Nan Luo; Yu Ko; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Qual Life Res       Date:  2009-10-15       Impact factor: 4.147

6.  Social relationships as a major determinant in the valuation of health states.

Authors:  Ulrich Frick; Hyacinth Irving; Jürgen Rehm
Journal:  Qual Life Res       Date:  2011-06-02       Impact factor: 4.147

7.  The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients.

Authors:  Chen-Wei Pan; Hong-Peng Sun; Xingzhi Wang; Qinghua Ma; Yong Xu; Nan Luo; Pei Wang
Journal:  Qual Life Res       Date:  2014-12-25       Impact factor: 4.147

8.  Impact of transformation of negative values and regression models on differences between the UK and US EQ-5D time trade-off value sets.

Authors:  Liv Ariane Augestad; Kim Rand-Hendriksen; Ivar Sønbø Kristiansen; Knut Stavem
Journal:  Pharmacoeconomics       Date:  2012-12-01       Impact factor: 4.981

9.  Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?

Authors:  Klazien Matter-Walstra; Dirk Klingbiel; Thomas Szucs; Bernhard C Pestalozzi; Matthias Schwenkglenks
Journal:  Pharmacoeconomics       Date:  2014-06       Impact factor: 4.981

10.  Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample.

Authors:  Dennis A Revicki; Ariane K Kawata; Neesha Harnam; Wen-Hung Chen; Ron D Hays; David Cella
Journal:  Qual Life Res       Date:  2009-05-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.